Ebola Update

Health officials confirm a case of Ebola in Liberia, which was declared free of transmissions in September.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDCWith the country’s first confirmed case since September, Liberia is no longer free of Ebola transmissions, health officials reported today (November 20), according to the Associated Press (AP). A 10-year-old boy who tested positive for the virus is now being treated outside Monrovia, the AP reported. World Health Organization (WHO) spokesperson Tarik Jasarevic confirmed the case in an interview with the Agence France-Presse.

Meanwhile, in its latest report, the WHO noted that there have been no new confirmed cases of Ebola in Guinea since October 29. But there is no official declaration yet of Guinea being rid of the virus. As The New York Times reported this week (November 17), “Guinea and other countries also run the risk of new cases generated from survivors who still harbor the virus in semen or body tissues.”

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development